EverGlade Consulting Blog
- New Strategy Leads to New Funding Opportunities for the Development of Medical Countermeasures In the wake of the Coronavirus Disease 2019 (COVID-19) pandemic and a rapidly expanding landscape of biological and chemical threats, the
- EverGlade Consulting (“EverGlade”), a national consulting firm, has helped a leading biotechnology company land an award from the Biomedical Advanced Research and Development Authority (BARDA) with a potential $1 billion in federal funding. This
- President Biden recently launched the administration’s new National Biodefense Strategy and Implementation Plan. The strategy reflects changing dynamics in Washington, especially given the lack of additional funding for COVID. National BiodefenseStrategy and Implementation Summarized
- As we enter a new era of diversity, equity, and inclusion in today’s evolving business ecosystem, Eric Jia-Sobota has been appointed to the Victory Fund Board of Directors. This appointment furthers both Eric and
- EverGlade Consulting (“EverGlade”), a national consulting firm, has successfully partnered with a global leader in mRNA materials used for research, diagnostics, and therapeutics, to successfully manage $39 million in federal funding. The Industrial Base
- As of August 10, the Center for Disease Control (CDC) reported that over 10,000 cases of monkeypox have been identified in the United States (US). The Biden administration officially declared monkeypox a Public Health